(Total Views: 508)
Posted On: 01/21/2021 9:13:18 PM
Post# of 151694
Let's say for the sake of argument that we are equal. The future of HIV treatments would basically be split between two companies. If that the worst case, I'm just fine with that.
Obviously I would rather have all of the market share. But I keep coming back to the fact that we need revenue so we can unlock the full potential of this molecule.
That's the big prize. COVID and HIV are the means to the end for Leronlimab. A way to get to the true potential.
So, what we need is SOME revenue. Not ALL of the revenue. Please keep this in mind.
Obviously I would rather have all of the market share. But I keep coming back to the fact that we need revenue so we can unlock the full potential of this molecule.
That's the big prize. COVID and HIV are the means to the end for Leronlimab. A way to get to the true potential.
So, what we need is SOME revenue. Not ALL of the revenue. Please keep this in mind.
(4)
(0)Scroll down for more posts ▼
